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Abstract
The introduction of combination antiretroviral therapy significantly reduced the prevalence of the
most severe form of HIV-associated neurocognitive disorders (HAND). Despite this decline, 35–
70% of HIV-infected patients continue to develop mild motor and cognitive impairments.
Although neuropsychological studies have shown that HAND affects a wide array of cognitive
functions, a formal diagnosis is still based on the exclusion of opportunistic infections and other
common ailments, as no specific tests or biomarkers are currently available. In this study, we used
magnetoencephalography (MEG) to measure neural activity during the resting-state in 15 HIV-
infected older patients and a demographically-matched group of 15 uninfected controls. MEG is a
noninvasive and direct measure of neural activity with excellent spatiotemporal resolution. All
MEG data were coregistered to structural MRI, corrected for head motion, fitted to a regional-
level source model, and subjected to spectral analyses to quantify population-level neural
oscillatory activity. We found that HIV-infected persons exhibited decreased beta oscillations in
the supplementary motor area bilaterally, paracentral lobule, posterior cingulate, and bilateral
regions of the superior parietal lobule relative to healthy controls. Beta oscillations in the posterior
cingulate, a critical component of the default mode network, were also positively correlated with
patient scores on the memory recall aspect of the Hopkins Verbal Learning Test-Revised. These
results demonstrate that chronic HIV infection does not uniformly disturb cortical function, and
that neuronal populations in dorso-medial motor and parietal cortices are especially affected.
These findings also suggest that resting-state MEG recordings may hold significant promise as a
functional biomarker for identifying HAND and monitoring disease progression.
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Introduction
Prior to the advent of combination antiretroviral therapy (cART), persons infected with the
human immunodeficiency virus type one (HIV) often developed severe cognitive
impairment, which was generally referred to as HIV-associated dementia (HAD; Adamson
et al, 1999; Bouwman et al, 1998). The prevalence of HAD has sharply decreased since
cART became widely available, although HIV-infected patients remain at an increased risk
for developing cognitive deficits with two milder forms of HAD widely recognized
(Antinori et al, 2007). Collectively, these disorders are referred to as HIV-associated
neurocognitive disorders (HAND), and overall they have persisted in the era of cART as
recent studies have shown that 35–70% of HIV-infected patients exhibit at least some form
of neuropsychological impairment (Heaton et al, 2010; Heaton et al, 2011; Simioni et al,
2010). The underlying source of this persistence remains uncertain. Furthermore, the basic
neural substrates of HAND have not been fully established, and to date the diagnosis of
HAND continues to be made by the exclusion of psychiatric disorders, opportunistic
infections, drug toxicities, and other factors. In short, there is currently no definitive
diagnostic test for HAND.
Clinical indices of disease severity such as CD4+ T-cell count have been used in
conjunction with neuropsychological testing, and structural MRI to better understand the
association between immune dysfunction, brain atrophy, and cognitive decline (Cohen et al,
2010; Jernigan et al, 2011; Thompson et al, 2005). Cohen et al. examined the association
between disease profiles, CD4+ count, duration of infection, and brain atrophy in
asymptomatic HIV-infected participants. They found that lower nadir CD4+ was correlated
with reduced white matter and that the duration of HIV infection was correlated with
reduced gray matter, indicating that the severity of immune suppression is coupled with
brain injury. Similarly, several studies have found that HIV-infected participants exhibit
diminished cortical gray matter thickness and cerebral volumes relative to non-infected
controls (Jernigan et al, 2011; Thompson et al, 2005). Furthermore, these volumetric
disparities were directly linked with the severity of cognitive decline, with HAD patients
displaying greater volumetric disparities than asymptomatic or mildly impaired patients
(Jernigan et al, 2011; Thompson et al, 2005). Studies using functional magnetic resonance
imaging (fMRI) have examined neuronal activity during attention and working memory
tasks in HIV-infected and un-infected participants, and found greater activation in the frontal
and parietal cortices of HIV-infected compared with control participants (Chang et al, 2001;
Chang et al, 2004; Chang et al, 2008; Ernst et al, 2002; Ernst et al, 2009). In particular,
Chang et al (2008) used a visual attention task with a variable attentional load during fMRI,
and revealed that HIV-infected participants had similar task accuracy and reaction times
relative to controls during less attention-demanding trials, but were less accurate and
exhibited altered blood-oxygen-level-dependent (BOLD) responses during the more
demanding trials. Finally, fMRI studies have also shown reduced activation and lower
resting cerebral-blood-flow in the primary visual cortices of HIV-infected participants
compared with controls (Ances et al, 2011; Ances et al, 2009; Ances et al, 2010).
In this study, we utilized magnetoencephalography (MEG) to examine cortical function in
HIV-infected and uninfected older persons during a resting-state task. We have previously
reported activity during visual processing, and finger tapping (Wilson et al, 2013a; Wilson
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et al, 2013c). MEG is a noninvasive, silent, and direct measure of neurophysiological
activity with excellent temporal and spatial precision. The method quantifies the minute
magnetic fields that naturally emanate from electrical activity in populations of active
neurons. Our primary goal in the current study was to identify cortical regions where there
was reduced oscillatory neuronal firing in HIV-infected participants compared with controls,
and to evaluate whether activity in these regions was predictive of neuropsychological
functioning. Such reductions in neural activity would likely indicate cortical atrophy in HIV-
infected patients (i.e., reduction in the number of local pyramidal cells), and/or reduced
neuronal synchronization within specific brain areas. Potentially, such functional indices of
neural activity may be more sensitive to early cortical atrophy than structural-based
measures, and thus provide improved options for early detection of HAND. As the
asymptomatic stage of HAND appears to be highly prevalent and difficult to diagnose, it is
of critical importance to understand and delineate a profile of disease progression with
respect to structural and functional brain abnormalities that precede cognitive decline
(Cysique and Brew, 2009; Gannon et al, 2011; Simioni et al, 2010). Based on the available
structural and functional neuroimaging literature, we hypothesized that HIV-infected
patients would show reduced neurophysiological activity in the bilateral precentral gyrus,
medial motor areas such as the supplementary motor area (SMA), parietal cortices, and
visual cortices. Moreover, we hypothesized that neural activity in these regions would
correlate with CD4+ count and neuropsychological measures of cognitive function in the
patient group.
Methods
We evaluated 15 HIV-infected adults (4 females) and 15 uninfected healthy controls (4
females). Controls were individually-matched to patients in regards to age, sex, and
ethnicity. At enrollment, HIV-infected participants were receiving effective cART and had
undetectable viremia. Exclusionary criteria included any pre-existing major psychiatric or
neurological disorder, active brain infection (except HIV-1), presence of brain neoplasm or
space-occupying lesion, history of head trauma, current substance abuse, and the MEG
Laboratory’s standard exclusion criteria (e.g., dental braces, metal implants, pacemakers,
etc.). Written informed consent was obtained following the guidelines of the University of
Nebraska Medical Center’s Institutional Review Board, who reviewed and approved the
study protocol.
Neuropsychological Assessments
All HIV-infected patients underwent a battery of neuropsychological testing. This battery
was sensitive, tested multiple domains, yet was relatively brief and convenient, and adhered
to the recommendations of the Frascati consensus (Antinori et al. 2007). The battery
assessed multiple functional domains including, gross motor (timed gait), fine motor
(grooved pegboard), language (WRAT 4 reading), verbal learning (Hopkins Verbal
Learning Test – Revised), verbal memory (HVLT-R), speed of processing (Trailmaking-A,
digit symbol), attention and working memory (Paced Auditory Serial Addition Task), and
executive functioning (verbal fluency, Stroop, and Trailmaking-B). All raw scores were
transformed to demographically-adjusted z-scores for the assessment of HAND and other
analyses. Correlation analyses were conducted on a subset of these neuropsychological
metrics and the MEG data (see below). Selection of this subset was based on the distribution
of scores across patients and the cognitive faculty probed by individual measures.
Experimental Paradigm
Throughout the paradigm, participants were seated within the magnetically-shielded room
with both arms resting on a tray attached to the chair body. Participants were instructed to
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relax, remain still, and fixate on a centrally-presented cross hair for one continuous six-
minute block.
Structural Magnetic Resonance Imaging (MRI)
High-resolution neuroanatomic images were acquired using a Philips Achieva 3T X-series
scanner. The T1-weighted sagittal images were obtained with an eight channel head coil
using a 3D fast field echo sequence with the following parameters: field of view, 24 cm;
slice thickness, 1 mm with no gap; in-plane resolution, 1.0 × 1.0 mm; sense factor, 1.5. The
structural volumes were aligned parallel to the anterior and posterior commissures and used
for MEG coregistration.
MEG Data Acquisition
All recordings were conducted in a one-layer magnetically-shielded room (MSR) with active
shielding engaged. With an acquisition bandwidth of 0.1 – 330 Hz, neuromagnetic responses
were sampled continuously at 1 kHz using an Elekta Neuromag system with 306 magnetic
sensors, including 204 planar gradiometers and 102 magnetometers (Elekta, Helsinki,
Finland). Using MaxFilter (v2.1.15; Elekta), MEG data from each session and subject were
individually-corrected for head motion, coregistered to structural MRI, and subjected to
noise reduction using the signal space separation method with a temporal extension (tSSS;
(Taulu and Simola, 2006; Taulu et al, 2005)
MEG Source Analyses
Following tSSS and head-motion correction, the sensor-level time series was divided into
epochs of 4096 ms duration (4096 points) and artifact rejection was performed using a fixed
threshold method supplemented with visual inspection. Artifact-free epochs were
transformed into a regional source model per participant via inverse spatial filtering using
the Brain Electrical Source Analysis software (BESA version 6.0; see Fig. 1; (Franzen et al,
2013; Hoechstetter et al, 2004; Wilson et al, 2013b). Essentially, a 29-point grid with dual
orthogonal orientations per point was constructed, and each orientation was used as an
inverse spatial filter on the continuous sensor-level time series data of the entire six-minute
recording, per participant (Franzen et al, 2013; Wilson et al, 2013b). After transformation
into source space, the current-amplitude (nAm) time series for each of the two orthogonal
orientations per source was transformed into the frequency domain using Fourier analyses
(i.e., 4096 data points per window). Average spectra across the six minute recording were
then computed for each orientation per brain region by averaging the ~90 Fourier-
transformed epochs. Subsequently, for each of the 29 regional sources, the amplitude per
band was summed across the two orthogonal orientations to yield the total current-amplitude
per frequency-band for the particular brain region. We focused on the local spectral
amplitude within the five traditional frequency bands of quantitative electroencephalography
(qEEG; i.e., delta: 1–4 Hz, theta: 4–7 Hz, alpha: 8–14 Hz, beta: 14–30 Hz, and gamma: 30–
56 Hz) using a repeated measures ANOVA analysis. Initially, we evaluated group
differences using an omnibus mixed-model ANOVA with brain region and frequency-band
as within-subjects factors, and group (HIV-infected, uninfected) as a between-subjects
factor. All statistical analyses were two-tailed and conducted in SPSS (Release 21.0.0). All
MEG pre-processing and source modeling used the BESA software (version 6.0), and MEG-
MRI coregistration and visualization used the BESA MRI (Version 2.0) software.
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Participant Demographics, Laboratory Test Results, & Neuropsychological Measures
Mean age was 56.79 years (range: 50–71) in the HIV-infected group and 58.47 years-old
(range: 50–75 years) in the control group. This difference was not significant (p = 0.24). The
mean duration of HIV diagnosis was 17 years (range: 10–22), the average CD4+ T-cell
count was 772 cells/mm3 (range: 267–1391), and all patients had undetectable viremia. Of
the 15 HIV-infected patients, seven were impaired in at least two domains and thus were
considered impaired according to the Frascati criteria (Antinori et al, 2007).
MEG Data
The omnibus 29 × 5 × 2 mixed-model ANOVA with location (29 brain regions) and
frequency bin (5 levels) as within-subjects factors, and group as a between-subjects factor
indicated that the three-way, brain region-by-frequency-by-group interaction effect was
significant F(112, 3136) = 1.37 (p < 0.01). In addition, the two-way brain region-by-group
interaction was significant F(28, 784) = 1.6 (p < 0.05), as was the brain region-by-frequency
interaction F(112, 3136) = 22.58 (p < 0.0001). Finally, the main effects of brain region and
frequency-band were significant (both p’s < 0.0001), but not the main effect of group (p =
0.52). No other effects were significant.
Given the focus of this study, follow-up testing was conducted on the significant three-way
and the two-way brain region-by-group interaction effects. Post-hoc t-tests (independent-
sample) of the brain region-by-frequency-by-group interaction term indicated that HIV-
infected participants had significantly weaker beta activity in the left SMA t(28) = 2.01 (p <
0.05; Cohen’s d = 0.76), left superior parietal lobule t(28) = 2.36 (p < 0.05; d = 0.89),
paracentral lobule t(28) = 2.6 (p < 0.05; d = 0.98), posterior cingulate t(28) = 2.02 (p < 0.05;
d = 0.76), and the right superior parietal lobule t(28) = 2.53 (p < 0.05; d = 0.96; see Fig. 2).
A marginal decrease in beta activity was also detected in the right SMA of HIV-infected
participants, t(28) = 1.79 (p = 0.08; d = 0.68; Fig. 2). To evaluate whether impairment status
modulated beta activity in these brain regions, we split the HIV-infected group into impaired
and unimpaired subgroups and performed an exploratory analysis which is shown in Table
1. Although preliminary, this analysis clearly suggested that impairment status is a critical
factor in the amplitude of beta oscillations in these brain regions. In regard to the brain
region-by-group interaction effect, post-hoc independent-sample t-tests showed that no
individual brain area was significantly different between groups when the amplitude of
neuronal activity was collapsed across all five frequency bands, but was marginally stronger
in the paracentral lobule t(28) = 1.93 (p = 0.06; d = 0.73) and the right superior parietal
lobule t(28) = 1.86 (p = 0.07; d = 0.70) of uninfected controls.
Neuropsychological, CD4, & MEG Correlations
To examine possible relationships between MEG measures of beta activity, CD4 T-cell
counts, and neuropsychological metrics, we conducted a series of Pearson-correlation
analyses in the HIV-infected participants. To this end, we used the beta amplitude value in
each brain region where significant group differences were found, and the participant scores
on individual neuropsychological assessments of fine motor control (Grooved Pegboard: z-
transformed dominant-hand score), psychomotor speed (z-transformed time score on Trail
Making Test A-B), memory function (z-transformed delayed-recall and retention indices of
the HVLT-R), speed of processing (z-transformed digit symbol), and executive functioning
(z-transformed color-word interference time on the Stroop task). Since these analyses were
restricted to brain areas where significant group differences were observed, we did not
correct p-values for multiple comparisons (e.g., using the Bonferroni method). Nonetheless,
these results should still be considered preliminary and interpreted with caution.
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These analyses showed that performance on the delayed recall measure of the HVLT-R was
significantly correlated with the amplitude of beta responses in the posterior cingulate, r(15)
= 0.52 (p < 0.05, two-tailed). In addition, the normalized color-word interference time on the
Stroop task was correlated with the amplitude of beta activity in the left SMA, r(15) = 0.59
(p < 0.05, two-tailed), and the right SMA, r(15) = 0.64 (p < 0.01, two-tailed). The amplitude
of beta oscillations was not correlated with performance measures on any other
neuropsychological assessment. Likewise, CD4+ T-cell counts at the time of the MEG
recording were not correlated with the amplitude of beta oscillations in brain regions where
group differences were observed.
Discussion
We examined regional neurophysiological activity during the awake resting-state in HIV-
infected older adults and a demographically-matched sample of uninfected healthy controls
using high-density MEG. Our results showed that HIV-infected participants had abnormally
reduced resting-state beta oscillations in the SMA bilaterally, paracentral lobule, posterior
cingulate, and bilateral regions of the superior parietal lobule when compared to healthy
uninfected controls. While we hypothesized that HIV-infected patients would show
diminished neural activity in the association, motor and visual cortices, we found that
differences in beta oscillations were primarily localized to dorsal motor and parietal areas,
along with one critical component of the default-mode network (Fox and Raichle, 2007;
Greicius and Menon, 2004; Raichle et al, 2001), the posterior cingulate. Interestingly,
patients’ scores on the HVLT-R delayed-recall measure were positively correlated with beta
oscillatory amplitudes in the posterior cingulate, which indicates that patients with the
highest HVLT-R recall scores were more similar to healthy controls. Likewise, neural
activity in the SMA bilaterally was correlated with performance on the Stroop task in HIV-
infected patients, with better performers having levels of neural activity similar to the
controls. Beyond theses brain regions, neither neuropsychological measures nor CD4+ count
was correlated with neural activity in any of the remaining brain regions. Below, we discuss
the implications of these findings for neuroimaging studies of HAND and current
understanding of the pathophysiological basis of these cognitive disorders.
In this study, HIV-infected patients exhibited abnormally reduced beta band oscillations in
dorsal and medial motor regions. Thompson et al (2005) found significantly decreased
cortical thickness in these same brain regions in HIV-infected patients relative to healthy
controls, and reported that the greatest differences in cortical thickness were in the SMA,
medial motor areas, and primary visual regions. Critically, with the exception of primary
visual regions, we found significantly decreased beta oscillations in the same brain regions
(i.e., medial sensorimotor and SMA). Such observations of brain atrophy and aberrant neural
activity (current study) in the sensorimotor cortices of the HIV-infected brain makes
intuitive sense, since less severe cases of HAD were originally referred to as minor cognitive
motor disorder (MCMD). Furthermore, our recent MEG study of motor performance in
HIV-infected patients found that HIV-infected participants exhibited increased beta activity
in the prefrontal cortices, as well as decreased beta responses in the SMA and precentral
gyrus relative to age- and sex-matched controls (Wilson et al, 2013c). This study also found
that the activation magnitudes in these motor regions were correlated with scores on the
Trail Making Test – B and Grooved Pegboard Test. Interestingly, recent neuropsychological
studies of HAND have also revealed that measures of psychomotor speed and fine motor
control are among the most sensitive assessments for HAND (Joska et al, 2010; Robertson
et al, 2007; Woods et al, 2005), which further implicates these brain areas as critically
deficient in HIV infection. In the current study we also found a significant correlation
between beta activity in the SMA and color-word inference time during the Stroop task in
HIV-infected patients. Presumably, this finding reflects the motor programming component
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of this task, although it is unclear why other motor assessments were not correlated with
MEG activity in these brain regions and this warrants future studies.
Sensory and motor information is integrated and manipulated in the parietal lobes so any
alteration to their functional or structural integrity may impair performance and result in
poor visuo-spatial processing (Koenigs et al, 2009). Thompson et al (2005) found that
cortical thickness in parietal regions was strongly correlated with neuropsychological
impairment in HIV-infected persons. In addition, proton magnetic resonance spectroscopy
findings from Ernst et al (2010) revealed that HIV-infected patients who exhibited poorer
performance on cognitive tests of attention had decreased glutamate levels in parietal gray
matter relative to healthy uninfected controls. Previous neuroimaging studies have also
suggested that neural activity patterns in prefrontal (supplementary motor areas) and parietal
cortices of HIV-infected patients are selectively altered during attentional and working
memory tasks in a load-dependent manner, arising during more difficult tasks requiring
greater attention and integration of complex stimuli (Chang et al, 2004; Chang et al, 2008;
Ernst et al, 2002; Ernst et al, 2009). The aforementioned studies utilized an fMRI visual
attention task requiring subjects to mentally track two, three, or four balls as they traveled
around a screen among 10 randomly moving balls. Essentially, every 10 seconds a set of
target balls, either the target set or a new set, was briefly highlighted and participants were
required to push a response button if the highlighted balls were the same as the original
targets. Using this task, Ernst et al (2009) recorded the BOLD responses of HIV-infected
patients over a one year period and found that although HIV-infected patients showed no
change in task performance, relative to healthy controls, they exhibited increased BOLD
responses in posterior parietal cortices. Ernst proposed that HIV-infected patients’ increased
neural activity represents a compensatory response involving the increased usage of the
brain’s reserve capacity in the dorsal attention network (DAN). A recent functional
connectivity study also found abnormalities in the DAN in HIV-infected patients (Thomas et
al (2013); described below).
Finally, we found decreased beta oscillations in the posterior cingulate, a critical component
of the DMN, which were correlated with patient scores on the memory recall aspect of the
HVLT-R, a test known to be sensitive to HAND (Carey et al, 2004; Woods et al, 2005).
Several fMRI studies have implicated the medial prefrontal cortices, posterior cingulate
cortices, and the mediolateral inferior parietal cortices as constituents of a cortical network
known as the default-mode network (Andrews-Hanna et al, 2010; Buckner et al, 2008;
Buckner and Vincent, 2007; Fox and Raichle, 2007; Greicius and Menon, 2004). The default
mode network has been characterized as a subset of cortical regions which exhibit greater
activation or increased neurophysiological activity during the resting-state as compared with
an active task state (Chang et al, 2004; Fox and Raichle, 2007; Fox et al, 2005; Wilson et al,
2013b). Interestingly, regions of the default-mode network also maintain a strong anti-
correlation with task-active regions, with activation being strongly suppressed across the
default-mode network during cognitive processing (Fox et al, 2005). As mentioned above,
we found that performance on the HVLT-R recall measure was positively correlated with
the amplitude of beta oscillations in the posterior cingulate in HIV-infected patients.
Essentially, patients with the highest scores had the strongest beta responses in this brain
area (i.e., were most like controls), which is consistent with the idea that neural activity
should be stronger in a “healthy” posterior cingulate during the resting-state. In accordance
with our findings, a recent study by Thomas et al (2013) examined resting-state functional
connectivity in HIV-infected patients using fMRI and found that patients exhibited
decreased functional connectivity in the DMN relative to healthy uninfected controls and
that neural activity was not correlated with either CD4+ count or cognitive impairment.
Thus, our findings are largely consistent with Thomas et al (2013), with the exception that
HVLT-R recall measures did correlate with the neural activity indices. As previously
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mentioned, Thomas et al (2013) found that HIV-infected patients exhibit aberrant resting-
state neural activity in the DAN, as well as significant reduction in the strength of the anti-
correlation between the DMN and DAN. Importantly, Thomas’ findings suggest that
abnormalities in the DMN may compromise the functional connectivity of other brain
networks resulting in cognitive impairments in integrating and processing stimuli.
Examining the activity of the DMN in the HIV-infected brain will provide critical insights
into understanding how HIV-related cerebral atrophy alters neuronal function. Resting state
data can then be juxtaposed to current attention network data to contribute understanding to
both the function of the DMN and the progression of HAND.
Beyond our recent study of motor function in HIV-infected patients (Wilson et al, 2013c),
only two MEG studies and one case study have been conducted in the HIV-infected
population. Nonetheless, together these studies have shown substantial promise in biomarker
development for HAND. The first MEG study in HIV-infected patients showed abnormal
mutual information between sensors in the anterior right part of the helmet and those in the
posterior left part (Becker et al, 2012a). Measures of mutual information are thought to
reflect connectivity, thus these findings suggest aberrant functional connectivity between
right frontal regions and left posterior areas in HIV-infected patients (Becker et al, 2012a),
which is consistent with the limited fMRI data on functional connectivity in this population
(Thomas et al, 2013). The second MEG study examined measurement reliability, and
provided preliminary evidence that broadband sensor-level data had good test-retest
reliability after ~24 weeks in both HIV-infected patients and controls (Becker et al, 2012c).
Finally, a recent case-study showed that MEG measurements of mutual information
improved to the level of uninfected controls following 6-months of cART administration to
a recently-diagnosed 54 year-old patient who was cART-naïve at enrollment (Becker et al,
2012b). Collectively, these studies complement the current study’s findings and provide
substantial support for the potential utility of MEG as a future test for HAND. Essentially,
based on our results, MEG appears to be sensitive to the degree of cognitive impairment and
may afford researchers the unique opportunity to investigate the relatively unexamined
asymptomatic form of HAND (ANI; Antinori et al (2007). If realized, this capacity would
open up new vistas for investigating the pathogenesis of HAND. One paradoxical problem
of developing MEG for this purpose is that there is no independent measure for validating
impairment below the threshold for ANI; such impairments are too subtle for existing
measures to detect. However, although speculative, longitudinal studies may be able to
provide partial validation to these measures as presumably patients with sub-threshold ANI
would progress to ANI over time. Nevertheless, MEG is a very promising technique in this
domain.
In closing, it is important to identify possible limitations in generalizing our findings to other
HIV neuroimaging studies. In our study, all HIV-infected patients were receiving effective
cART during the study, and at this time it is unknown how such therapy modulates neuronal
activity. In regards to the limited neurobehavioral and neuroimmune (e.g., CD4+)
correlations in the current study, many other neuroimaging studies have also failed to find
such correlations (Ances et al, 2009; Chang et al, 2008; Thomas et al, 2013). In fact, only a
few previous studies have actually indicated a relationship between neuronal activity,
neuropsychological deficits, and depressed CD4+ counts in HIV-infected persons (Jernigan
et al, 2011; Thompson et al, 2005; Wilson et al, 2013c), and future studies should evaluate
other factors that may mediate this relationship. Another possible factor that may limit the
generalizability of study is that all of our patients had relatively high CD4+ counts, which
may influence behavioral and neuroimaging measurements. Our cohort also consisted of
older adults infected with HIV so our findings cannot be easily generalized to younger
patients. Future studies should use larger sample sizes, wider age ranges, and evaluate the
contributions of comorbidities to HAND in HIV-infected patients receiving cART.
Becker et al. Page 8














This work was supported by NIH grant P30 MH062261 (HSF). The Center for Magnetoencephalography at the
University of Nebraska Medical Center was founded through an endowment from an anonymous donor. We would
like to thank our participants for volunteering. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
References
Adamson DC, McArthur JC, Dawson TM, Dawson VL. Rate and severity of HIV-associated dementia
(HAD): correlations with Gp41 and iNOS. Mol Med. 1999; 5:98–109. [PubMed: 10203575]
Ances B, Vaida F, Ellis R, Buxton R. Test-retest stability of calibrated BOLD-fMRI in HIV− and HIV
+ subjects. Neuroimage. 2011; 54:2156–62. [PubMed: 20932922]
Ances BM, Sisti D, Vaida F, Liang CL, Leontiev O, Perthen JE, Buxton RB, Benson D, Smith DM,
Little SJ, Richman DD, Moore DJ, Ellis RJ, group H. Resting cerebral blood flow: a potential
biomarker of the effects of HIV in the brain. Neurology. 2009; 73:702–8. [PubMed: 19720977]
Ances BM, Vaida F, Yeh MJ, Liang CL, Buxton RB, Letendre S, McCutchan JA, Ellis RJ. HIV
infection and aging independently affect brain function as measured by functional magnetic
resonance imaging. J Infect Dis. 2010; 201:336–40. [PubMed: 20047503]
Andrews-Hanna JR, Reidler JS, Sepulcre J, Poulin R, Buckner RL. Functional-anatomic fractionation
of the brain’s default network. Neuron. 2010; 65:550–62. [PubMed: 20188659]
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG,
Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn
M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research
nosology for HIV-associated neurocognitive disorders. Neurology. 2007; 69:1789–99. [PubMed:
17914061]
Becker JT, Bajo R, Fabrizio M, Sudre G, Cuesta P, Aizenstein HJ, Lopez OL, Wolk D, Parkkonen L,
Maestu F, Bagic A. Functional connectivity measured with magnetoencephalography identifies
persons with HIV disease. Brain Imaging Behav. 2012a; 6:366–73. [PubMed: 22328062]
Becker JT, Cuesta P, Fabrizio M, Sudre G, Vergis EN, Douaihy A, Bajo R, Schubert A, Lopez OL,
Parkkonen L, Maestu F, Bagic A. Brain structural and functional recovery following initiation of
combination antiretroviral therapy. J Neurovirol. 2012b; 18:423–7. [PubMed: 22692914]
Becker JT, Fabrizio M, Sudre G, Haridis A, Ambrose T, Aizenstein HJ, Eddy W, Lopez OL, Wolk
DA, Parkkonen L, Bagic A. Potential utility of resting-state magnetoencephalography as a
biomarker of CNS abnormality in HIV disease. J Neurosci Methods. 2012c; 206:176–82. [PubMed:
22414786]
Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ,
McArthur JC. Variable progression of HIV-associated dementia. Neurology. 1998; 50:1814–20.
[PubMed: 9633733]
Buckner RL, Andrews-Hanna JR, Schacter DL. The brain’s default network: anatomy, function, and
relevance to disease. Ann N Y Acad Sci. 2008; 1124:1–38. [PubMed: 18400922]
Buckner RL, Vincent JL. Unrest at rest: default activity and spontaneous network correlations.
Neuroimage. 2007; 37:1091–6. discussion 1097–9. [PubMed: 17368915]
Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, Marcotte TD, Grant I, Heaton RK, Group
H. Initial validation of a screening battery for the detection of HIV-associated cognitive
impairment. Clin Neuropsychol. 2004; 18:234–48. [PubMed: 15587671]
Chang L, Speck O, Miller EN, Braun J, Jovicich J, Koch C, Itti L, Ernst T. Neural correlates of
attention and working memory deficits in HIV patients. Neurology. 2001; 57:1001–7. [PubMed:
11571324]
Chang L, Tomasi D, Yakupov R, Lozar C, Arnold S, Caparelli E, Ernst T. Adaptation of the attention
network in human immunodeficiency virus brain injury. Ann Neurol. 2004; 56:259–72. [PubMed:
15293278]
Chang L, Yakupov R, Nakama H, Stokes B, Ernst T. Antiretroviral treatment is associated with
increased attentional load-dependent brain activation in HIV patients. J Neuroimmune Pharmacol.
2008; 3:95–104. [PubMed: 18247124]
Becker et al. Page 9













Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P,
Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT,
Navia B. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on
brain volumes in the highly active antiretroviral therapy era. J Neurovirol. 2010; 16:25–32.
[PubMed: 20113183]
Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a
review. Neuropsychol Rev. 2009; 19:169–85. [PubMed: 19424802]
Ernst T, Chang L, Jovicich J, Ames N, Arnold S. Abnormal brain activation on functional MRI in
cognitively asymptomatic HIV patients. Neurology. 2002; 59:1343–9. [PubMed: 12427881]
Ernst T, Jiang CS, Nakama H, Buchthal S, Chang L. Lower brain glutamate is associated with
cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder. J
Magn Reson Imaging. 2010; 32:1045–53. [PubMed: 21031507]
Ernst T, Yakupov R, Nakama H, Crocket G, Cole M, Watters M, Ricardo-Dukelow ML, Chang L.
Declined neural efficiency in cognitively stable human immunodeficiency virus patients. Ann
Neurol. 2009; 65:316–25. [PubMed: 19334060]
Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic
resonance imaging. Nat Rev Neurosci. 2007; 8:700–711. [PubMed: 17704812]
Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. The human brain is
intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S
A. 2005; 102:9673–8. [PubMed: 15976020]
Franzen JD, Heinrichs-Graham E, White ML, Wetzel MW, Knott NL, Wilson TW. Atypical coupling
between posterior regions of the default mode network in attention-deficit/hyperactivity disorder: a
pharmaco-magnetoencephalography study. J Psychiatry Neurosci. 2013; 38:120054.
Gannon P, Khan MZ, Kolson DL. Current understanding of HIV-associated neurocognitive disorders
pathogenesis. Curr Opin Neurol. 2011; 24:275–83. [PubMed: 21467932]
Greicius MD, Menon V. Default-mode activity during a passive sensory task: uncoupled from
deactivation but impacting activation. J Cogn Neurosci. 2004; 16:1484–92. [PubMed: 15601513]
Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte
TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB,
McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-
Notestine C, Jernigan TL, Wong J, Grant I, Group C. HIV-associated neurocognitive disorders
persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010; 75:2087–
96. [PubMed: 21135382]
Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA,
Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD,
Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A,
Fennema-Notestine C, Jernigan TL, Wong J, Grant I, Group C, Group H. HIV-associated
neurocognitive disorders before and during the era of combination antiretroviral therapy:
differences in rates, nature, and predictors. J Neurovirol. 2011; 17:3–16. [PubMed: 21174240]
Hoechstetter K, Bornfleth H, Weckesser D, Ille N, Berg P, Scherg M. BESA source coherence: a new
method to study cortical oscillatory coupling. Brain Topogr. 2004; 16:233–8. [PubMed:
15379219]
Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine
RJ, Wolfson T, Letendre SL, Ellis RJ, Heaton RK, Gamst AC, Franklin DR Jr, Clifford DB,
Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant
I, Group C. Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol.
2011; 17:248–57. [PubMed: 21544705]
Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ. Does highly active antiretroviral therapy improve
neurocognitive function? A systematic review. J Neurovirol. 2010; 16:101–14. [PubMed:
20345318]
Koenigs M, Barbey AK, Postle BR, Grafman J. Superior parietal cortex is critical for the manipulation
of information in working memory. J Neurosci. 2009; 29:14980–6. [PubMed: 19940193]
Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of
brain function. Proc Natl Acad Sci U S A. 2001; 98:676–682. [PubMed: 11209064]
Becker et al. Page 10













Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans
SR, Ellis RJ. The prevalence and incidence of neurocognitive impairment in the HAART era.
AIDS. 2007; 21:1915–21. [PubMed: 17721099]
Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave
JP, Giacobini E, Hirschel B, Du Pasquier RA. Cognitive dysfunction in HIV patients despite
longstanding suppression of viremia. AIDS. 2010; 24:1243–50. [PubMed: 19996937]
Taulu S, Simola J. Spatiotemporal signal space separation method for rejecting nearby interference in
MEG measurements. Phys Med Biol. 2006; 51:1759–68. [PubMed: 16552102]
Taulu S, Simola J, Kajola M. Applications of the signal space separation method (SSS). IEEE Trans
Signal Process. 2005; 53:3359–3372.
Thomas JB, Brier MR, Snyder AZ, Vaida FF, Ances BM. Pathways to neurodegeneration: effects of
HIV and aging on resting-state functional connectivity. Neurology. 2013; 80:1186–93. [PubMed:
23446675]
Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, Becker JT. Thinning
of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl
Acad Sci U S A. 2005; 102:15647–52. [PubMed: 16227428]
Wilson TW, Fox HS, Robertson KR, Sandkovsky U, O’Neill J, Heinrichs-Graham E, Knott NL,
Swindells S. Abnormal MEG Oscillatory Activity during Visual Processing in the Prefrontal
Cortices and Frontal Eye-Fields of the Aging HIV Brain. PLoS One. 2013a; 8:e66241. [PubMed:
23840428]
Wilson TW, Franzen JD, Heinrichs-Graham E, White ML, Knott NL, Wetzel MW. Broadband
neurophysiological abnormalities in the medial prefrontal region of the default-mode network in
adults with ADHD. Hum Brain Mapp. 2013b; 34:566–74. [PubMed: 22102400]
Wilson TW, Heinrichs-Graham E, Robertson KR, Sandkovsky U, O’Neill J, Knott NL, Fox HS,
Swindells S. Functional Brain Abnormalities During Finger-Tapping in HIV-Infected Older
Adults: A Magnetoencephalography Study. J Neuroimmune Pharmacol. 2013c
Woods SP, Scott JC, Dawson MS, Morgan EE, Carey CL, Heaton RK, Grant I, Group HIVNRC.
Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an
HIV-1 sample. Arch Clin Neuropsychol. 2005; 20:1061–71. [PubMed: 16198529]
Becker et al. Page 11














Representative Example of the 29-node Regional Source Model. For each participant, a 29-
node (grid-point) model with dual orthogonal orientations was fitted to the T1-weighted
MRI following coregistrati on. This model was used to estimate regional neuronal activity
during the resting-state MEG recording using inverse spatial filtering. In the figure above,
the model can be seen overlaid on the MRI of a HIV-infected participant. The same 3D
rendition is shown in both the left and right panels, although the orientation of the image
differs between the two panels to facilitate visualization of the spatial location of each
source. For example, using the left panel one can discern that the regional sources that
appear to be in the orbits on the right panel are actually located in the ventral prefrontal
cortices. Likewise, the nodes that appear to be located within the sinuses on the right panel
can be discerned as medial frontal sources using the left panel. The different colors are only
meant to aid in visually distinguishing the regional sources. Note that the regional sources
are spaced equidistant apart and that each represents activity over an extended cortical area
(i.e., > 1cm3). Thus, the time series of each node reflects the average neuronal activity over
that brain region, and not the amount of activation at a precise neuroanatomical coordinate
(e.g., a voxel in MNI space). Following spectral analyses, the current amplitude (in nAm)
was summed across the dual orthogonal orientations to yield the total amplitude for the
given brain region.
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HIV-related Neuronal Activity Differences during the Resting-State. Neuronal activity in the
beta-band (14–30 Hz) was significantly reduced in superior parietal areas, medial motor
regions, and the posterior cingulate of HIV-infected patients (red) compared to uninfected
controls (black) during the awake resting-state. Neuronal activity in the other frequency bins
did not significantly differ between patients and controls. Error bars indicate one standard
error of the mean. PCC: posterior cingulate; SMA: supplementary motor area; * = p < 0.05;
† = p < 0.08
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Table 1
MEG Results by Impairment Status in the HIV-Infected Group
Brain Region Impaired Mean(SD) Unimpaired Mean(SD) t-value p-value
L SMA 163.31(40) 227.35(53) −2.620 0.021
L Superior Parietal 146.50(20) 205.23(49) −2.971 0.011
Paracentral Lobule 147.50(32) 186.60(37) −2.149 0.051
PCC 127.36(23) 180.75(39) −3.158 0.008
R SMA 163.56(33) 224.78(40) −3.245 0.006
R Superior Parietal 152.13(22) 208.71(53) −2.598 0.022
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